Czech Republic: Market for Medicaments Of Alkaloids Or Derivatives Thereof 2022

Market Size for Medicaments Of Alkaloids Or Derivatives Thereof in the Czech Republic

The Czech market for medicaments of alkaloids or derivatives thereof was finally on the rise to reach $X in 2021, after two years of decline. In general, consumption, however, recorded a slight decline. Consumption of peaked at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Production of Medicaments Of Alkaloids Or Derivatives Thereof in the Czech Republic

In value terms, production of medicaments of alkaloids or derivatives thereof rose modestly to $X in 2021 estimated in export price. Over the period under review, production, however, showed a perceptible downturn. Production of peaked at $X in 2012; however, from 2013 to 2021, production remained at a lower figure.

Exports of Medicaments Of Alkaloids Or Derivatives Thereof

Exports from the Czech Republic

In 2019, exports of medicaments of alkaloids or derivatives thereof from the Czech Republic skyrocketed to X tons, growing by X% against 2018. Overall, total exports indicated a noticeable increase from 2012 to 2019: its volume increased at an average annual rate of +X% over the last seven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2019 figures, exports increased by +X% against 2013 indices. The most prominent rate of growth was recorded in 2016 when exports increased by X% against the previous year. The exports peaked in 2019 and are expected to retain growth in the near future.

In value terms, exports of medicaments of alkaloids or derivatives thereof reduced slightly to $X in 2019. In general, exports showed a strong increase. The pace of growth appeared the most rapid in 2014 with an increase of X%. The exports peaked at $X in 2016; however, from 2017 to 2019, the exports stood at a somewhat lower figure.

Exports by Country

Slovakia (X tons), Spain (X tons) and Ukraine (X tons) were the main destinations of exports of medicaments of alkaloids or derivatives thereof from the Czech Republic, with a combined X% share of total exports. Malaysia, the United States, Denmark and Poland lagged somewhat behind, together accounting for a further X 2012 to 2019, the biggest increases were in Denmark (with a CAGR of +X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, Denmark ($X) remains the key foreign market for medicaments of alkaloids or derivatives thereof exports from the Czech Republic, comprising X% of total exports. The second position in the ranking was held by Ukraine ($X), with a X% share of total exports. It was followed by Slovakia, with a X% share.

From 2012 to 2019, the average annual rate of growth in terms of value to Denmark totaled +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Ukraine (+X% per year) and Slovakia (-X% per year).

Export Prices by Country

In 2019, the average export price for medicaments of alkaloids or derivatives thereof amounted to $X per ton, reducing by -X% against the previous year. Overall, export price indicated notable growth from 2012 to 2019: its price increased at an average annual rate of +X% over the last seven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2019 figures, export price for medicaments of alkaloids or derivatives thereof decreased by -X% against 2014 indices. The pace of growth appeared the most rapid in 2014 when the average export price increased by X% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2015 to 2019, the the average export prices remained at a lower figure.

There were significant differences in the average prices for the major foreign markets. In 2019, the country with the highest price was Denmark ($X per ton), while the average price for exports to Spain ($X per ton) was amongst the lowest.

From 2012 to 2019, the most notable rate of growth in terms of prices was recorded for supplies to Denmark (+X%), while the prices for the other major destinations experienced a decline.

Imports of Medicaments Of Alkaloids Or Derivatives Thereof

Imports into the Czech Republic

For the third consecutive year, the Czech Republic recorded decline in purchases abroad of medicaments of alkaloids or derivatives thereof, which decreased by -X% to X tons in 2019. In general, imports saw a noticeable decline. The pace of growth appeared the most rapid in 2016 with an increase of X%. As a result, imports reached the peak of X tons. From 2017 to 2019, the growth of imports of failed to regain momentum.

In value terms, imports of medicaments of alkaloids or derivatives thereof fell modestly to $X in 2019. Overall, imports, however, continue to indicate a relatively flat trend pattern. The pace of growth appeared the most rapid in 2014 when imports increased by X%. As a result, imports attained the peak of $X. From 2015 to 2019, the growth of imports of remained at a lower figure.

Imports by Country

In 2019, Germany (X tons) constituted the largest medicaments of alkaloids or derivatives thereof supplier to the Czech Republic, accounting for a X% share of total imports. Moreover, imports of medicaments of alkaloids or derivatives thereof from Germany exceeded the figures recorded by the second-largest supplier, Poland (X tons), threefold. The third position in this ranking was held by France (X tons), with an X% share.

From 2012 to 2019, the average annual growth rate of volume from Germany totaled +X%. The remaining supplying countries recorded the following average annual rates of imports growth: Poland (+X% per year) and France (+X% per year).

In value terms, Germany ($X) constituted the largest supplier of medicaments of alkaloids or derivatives thereof to the Czech Republic, comprising X% of total imports. The second position in the ranking was held by the UK ($X), with a X% share of total imports. It was followed by Spain, with a X% share.

From 2012 to 2019, the average annual growth rate of value from Germany amounted to +X%. The remaining supplying countries recorded the following average annual rates of imports growth: the UK (+X% per year) and Spain (+X% per year).

Import Prices by Country

In 2019, the average import price for medicaments of alkaloids or derivatives thereof amounted to $X per ton, with an increase of X% against the previous year. Over the period under review, import price indicated noticeable growth from 2012 to 2019: its price increased at an average annual rate of +X% over the last seven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2019 figures, import price for medicaments of alkaloids or derivatives thereof increased by +X% against 2016 indices. The pace of growth was the most pronounced in 2013 when the average import price increased by X%. Over the period under review, average import prices hit record highs at $X per ton in 2014; however, from 2015 to 2019, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2019, the country with the highest price was the UK ($X per ton), while the price for the Netherlands ($X per ton) was amongst the lowest.

From 2012 to 2019, the most notable rate of growth in terms of prices was attained by Spain (+X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :